Sunshine Biopharma Inc Earnings: Miss on EPS and Revenue
Sunshine Biopharma Inc (SBFM) missed Q1 2026 expectations with -$0.54 EPS vs -$0.28 estimate and $8.57M revenue vs $10.20M expected, representing significant shortfalls.
Sunshine Biopharma Inc (SBFM) missed Q1 2026 expectations with -$0.54 EPS vs -$0.28 estimate and $8.57M revenue vs $10.20M expected, representing significant shortfalls.
R C M Technologies Inc beat EPS estimates with $0.77 vs $0.63 expected (21.76% surprise) and revenue of $86.48M vs…
Sunshine Biopharma Inc (SBFM) missed Q2 2026 EPS estimates with -$0.54 vs -$0.28 expected and revenue of $8.58M vs $10.20M…
RCMT beat Q2 2026 EPS estimates with $0.77 vs $0.63 expected (21.76% surprise) while revenue of $86.48M slightly topped $86.15M…
NISA is Japan's tax-free investment account. Learn how the New NISA works, annual limits (¥3.6M), lifetime limit (¥18M), who can…
PGOL reports quarterly earnings on April 7, 2026. With no analyst estimates available yet, investors will focus on revenue trends…
GBX reports Q1 2026 earnings April 7 with analysts expecting $0.83 EPS and $670M revenue. Key focus on railcar demand…
Blackrock MuniHoldings Quality Fund II (MUE) reports earnings April 7, 2026. Key focus on NAV performance, distribution coverage, and municipal…
Wells Fargo reports Q1 2026 earnings on April 14. EPS estimate $1.57. What to watch including the asset cap, net…
JPMorgan Chase reports Q1 2026 earnings on April 14. EPS estimate $5.43. What analysts expect, key macro risks to watch,…